why C4 Therapeutics Inc [CCCC] is a Good Choice for Investors After New Price Target of $16.50
C4 Therapeutics Inc [NASDAQ: CCCC] price surged by 21.38 percent to reach at $1.55. The company report on February 22, 2024 at 7:00 AM that C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights. CFT1946 Preclinical Data Accepted for